Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different Target-Controlled Infusion Concentrations of Remifentanil with Propofol in Gynecologic Laparoscopic Surgery
ChiCTR2000040130Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Nov 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remifentanil and propofol in Delayed postoperative recovery (DPR) (4 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoints: Patient state index (PSI) and Bispectral index (BIS). Started Nov 2020; status: recruiting.
02
Drugs
remifentanilpropofol
03
Conditions
Delayed postoperative recovery (DPR)
Beyond the preview
Go deeper on ChiCTR2000040130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040130.